In our study, we found that wild-type SLC26A4 significantly activated, while SLC26A4 mutants inhibited the PI3K/Akt/mTOR pathway in HEK-293T cells, suggesting that this pathway may be another important mechanism of SLC26A4 mutants in hearing loss. This evidence concerns the gene SLC26A4 and hearing loss disorder.